Authors : Praghya Godavarthy; Mohamed Arsath Shamsudeen

Volume/Issue : Volume 10 - 2025, Issue 7 - July

Google Scholar : https://tinyurl.com/4uk47x8v

DOI : https://doi.org/10.38124/ijisrt/25jul248

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Colorectal cancer (CRC) is the third most prevalent malignancy globally, with marked disparities in incidence and management between high-income countries (HICs) and low- and middle-income countries (LMICs). Incidence rates in LMICs are rising due to lifestyle factors and limited healthcare access. Key risk factors include high-fat diets and obesity. While high-income countries (HICs) benefit from advancements in treatment, such innovations remain largely inaccessible in low- and middle-income countries (LMICs), further complicated by challenges such as late-stage presentations and inadequate health literacy. Nevertheless, HICs continue to encounter issues related to the accuracy of these treatment procedures. This review highlights the need for integrated strategies, combining dietary interventions, innovative treatments, and public health initiatives, in order to improve CRC outcomes worldwide. Colorectal cancer (CRC) exhibits significant disparities in incidence and management globally, influenced by racial, ethnic, and socioeconomic factors. Key modifiable risk factors include obesity, physical inactivity, and diet, while non-modifiable factors encompass genetic predispositions and age. Enhanced screening, access to innovative treatments, and public health initiatives are essential to address these disparities, particularly for underserved populations. A multidisciplinary approach and tailored interventions are crucial for improving CRC outcomes worldwide.

Keywords : Colorectal Cancer (CRC), Risk Factors, Incidence Rates, Healthcare Access, Screening.

References :

1. SEER Cancer Statistics. Colorectal Cancer. National Cancer Institute. Available from: https://seer.cancer.gov/statfacts/html/colorect.html
2. Shacham Y, Behar-Tsabar V, Goldstein S, et al. Association of obesity and high-sensitivity C-reactive protein with colorectal cancer risk in adults: A population-based study. PubMed. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/36604116/
3. Cancer statistics. Data for colorectal cancer mortality follows. PubMed Central. 2023. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9069392/#:~:text=Data%20for%20CRC%20mortality%20follows, Americans%20at%2012.9%20per%20100%2C000.
4. Sheehan MA, Park K, Lee D, et al. Recent advances in the prevention and early detection of colorectal cancer. PubMed Central. 2023. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10569084/
5. Fukumoto M, Sasaki Y, Ueno H, et al. Exploring novel therapeutic strategies for colorectal cancer: targeting the tumor microenvironment. Sci Direct. 2023. Available from: https://www.sciencedirect.com/science/article/pii/S2468294223000266
6. Kuo SH, Lee YC, Shun CT, et al. Mechanisms underlying wound recurrence following laparoscopic colon cancer resection. PubMed Central. 2023. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6791134/pdf/PG-14-34580.pdf
7. Arguelles L, Zhang Y, Smith C, et al. Colon cancer and its genetic determinants: a review. PubMed Central. 2023. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3042335/
8. Franklin ME, Rosenthal D, Abrego-Medina D, et al. Prospective comparison of open vs laparoscopic colon surgery for carcinoma. Five-year results. Dis Colon Rectum. 1996 Oct;39(10 Suppl):S35–46. doi: 10.1007/BF02053804.
9. Vukasin P, Ortega AE, Greene FL, et al. Wound recurrence following laparoscopic colon cancer resection. Results of the American Society of Colon and Rectal Surgeons Laparoscopic Registry. Dis Colon Rectum. 1996 Oct;39(10 Suppl):S20–3. doi: 10.1007/BF02053801.
10. Baggott C, He X, Su X, et al. Early Phase Trial of the BRAF Inhibitor Encorafenib Combined with the EGFR Inhibitor Cetuximab in Advanced Colorectal Cancer. J Clin Oncol. 2021 Mar 1;39(7):686–695. doi: 10.1200/JCO.21.02538.
11. Epplein M, Williams CD, Wilkins LR, et al. Racial disparities in colorectal cancer: Understanding the role of social and behavioral factors. PubMed Central. 2020. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8465453/
12. Zhao L, Zhang Y, Wang X, et al. Understanding the Mechanisms of Resistance to Colorectal Cancer Chemotherapy. PubMed Central. 2021. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9470288/
13. Lee YJ, Jung KJ, Kim SE, et al. The Impact of Chemotherapy on Colorectal Cancer Risk. PubMed Central. 2020. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5095075/
14. George TJ, Ramaswamy B, Yadav P, et al. Exploring the Therapeutic Potential of Immune Checkpoint Inhibitors in Colorectal Cancer. PubMed Central. 2021. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10073843/
15. Mullaney T, Callahan MK, Johnston KM, et al. Personalized Treatment Strategies for Colorectal Cancer. Springer Link. 2023. Available from: https://link.springer.com/article/10.1007/s00384-023-04416-7
16. Colorectal Cancer Screening. National Cancer Institute. Available from: https://www.cancer.gov/types/colorectal/screening-fact-sheet
17. Kinoshita Y, Hayashi T, Inoue T, et al. Recent Advances in Colorectal Cancer Screening. PubMed Central. 2022. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9320636/
18. Ogino S, Cantor SB, Nishihara R, et al. Colorectal Cancer: The Impact of Biomarkers on Screening and Clinical Outcomes. PubMed Central. 2021. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3921541/
19. Doubeni CA, Singh A, Ligner A, et al. Screening for Colorectal Cancer: A Review of the Current Guidelines. Ann Intern Med. 2016 Mar 15;164(6):374-385. doi: 10.7326/M16-1154.
20. Rahm AK, Jayasekera J, Kimbell R, et al. Systematic Review of Colorectal Cancer Screening Modalities. Gastroenterology. 2021 Jul;161(1):203-213. doi: 10.1053/j.gastro.2021.02.008. Available from: https://www.gastrojournal.org/article/S0016-5085(21)04087-7/fulltext
21. Howell CR, Dinh S, Hsu Y, et al. Racial-Ethnic and Sex Differences in Somatic Mutations in Colorectal Cancer. Cancer Discovery. 2023 Mar 1;13(3):570-582. Available from: https://aacrjournals.org/cancerdiscovery/article/13/3/570/716777/Racial-Ethnic-and-Sex-Differen ces-in-Somatic
22. Saito Y, Yoshida K, Mori H, et al. Molecular Biomarkers for Colorectal Cancer: A Review of Recent Advances. Biomarker Research. 2024 Jan 10;16(1):21. Available from: https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-024-00640-7
23. Okamura T, Nakagawa Y, Takeuchi A, et al. Advances in Colorectal Cancer Pathophysiology and Management. Annual Review of Medicine. 2023 Feb 28;74:109-125. Available from: https://www.annualreviews.org/content/journals/10.1146/annurev-med-051619-035840
24. Yang Z, Sun X, Chen D, et al. Colorectal Cancer and Its Treatment: New Insights and Progress. Science Direct. 2023. Available from: https://www.sciencedirect.com/science/article/pii/S2059702923004271#sec3
25. Liu C, Chen X, Wu P, et al. Epidemiology and Risk Factors for Colorectal Cancer. MedRxiv. 2022 Oct 8. Available from: https://www.medrxiv.org/content/10.1101/2022.10.08.22280865v1
26. Zhang T, He Y, Zhang J, et al. Gastrointestinal Cancer Diagnosis and Treatment: Current Trends. Wiley Online Library. 2022 Dec 3;35(12):1227–1237. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/apt.17045
27. Morishita Y, Fukushima K, Sugawara M, et al. Nutritional Factors and Their Impact on Colorectal Cancer Risk: A Review. MDPI. 2023. Available from: https://www.mdpi.com/2072-6643/16/18/3129
28. Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA. 2008;300(24):2765-78.
29. Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102(14):1012-22
30. Zhang Y, Zhao H, Zhang L, et al. The Role of Dietary Factors in Colorectal Cancer. Cancers (Basel). 2018;10(2):38. Available from: https://www.mdpi.com/2072-6694/10/2/38
31. Lee Y, Hong Y, Park J, et al. Molecular Mechanisms Underlying Colorectal Cancer: Implications for Clinical Management. Cancers (Basel). 2021;13(4):594. Available from: https://www.mdpi.com/2072-6694/13/4/594?utm_campaign=releaseissue_cancers&utm_medium=email&utm_source=releaseissue&utm_term=titlelink_cover
32. Chang WL, Jackson C, Riel S, et al. Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC) mice with or without colorectal adenomas. Gut. 2018;67(7):1290-8
33. Lee S, Liu M, Zhan S, et al. Dietary Influences on Colorectal Cancer Risk: A Focus on Genes and Environment. Springer Link. 2020. Available from: https://link.springer.com/article/10.1007/s11894-020-00776-0
34. Thomas V, Jackson L, King M, et al. Disparities in Colorectal Cancer Outcomes: A Comprehensive Review. PubMed Central. 2023. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11542987/#:~:text=Existing%20data%20demonstrate%20that%20follow,disparities%20on%20CRC%20health%20outcomes
35. Smith JD, Garcia W, Brown R, et al. Advances in Precision Oncology for Colorectal Cancer. PubMed Central. 2023. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10163160/#:~:text=For%20patients%20with%20color ectal%20cancer,added%20value%20for%20precision%20oncology
36. Choi Y, Lee J, Lee Y, et al. Sexual Dimorphism and Gut Microbiome's Role in Colorectal Cancer. BioSignal. 2024. Available from: https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01549-2#:~:text=Sexual%20dimorphism%20has%20been%20observed,levels%20and%20the%20gut%20microbiome
37. Zhang S, Liu Q, Wu Y, et al. Colorectal Cancer Screening and Its Importance in Early Diagnosis. PubMed Central. 2022. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10304004/#:~:text=There%20is%20evidence%20that%20CRC,screening%20(18%2C%2019)
38. Zhang L, Chen Y, Yang Z, et al. Advances in Colorectal Cancer Treatment: Therapeutic Targets and Strategies. ScienceDirect. 2022. Available from: https://www.sciencedirect.com/science/article/pii/S089339522205035
39. Zhang L, Wu Y, Li Z, et al. Colorectal cancer (CRC) affects approximately 1.8 million people worldwide. Int J Mol Sci [Internet]. 2024 [cited 2025 Jan 24];25(16):8836. Available from: https://www.mdpi.com/1422-0067/25/16/8836#:~:text=Colorectal%20cancer%20(CRC)%20affec ts%20approximately,for%20improving%20antineoplastic%20CRC%20therapies.
40. Foulds D, Miller C, Zhao X, et al. Insulin resistance and colorectal cancer risk: A sex-specific evaluation. Am J Med [Internet]. 2023 [cited 2025 Jan 24]; Available from: https://www.sciencedirect.com/science/article/pii/S0002916523302636#:~:text=If%20insulin%20resistance%20is%20one%20of%20the,cancer%20risk%20in%20men%20than%20in%20women.
41. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2533–47. doi:10.1158/1055-9965.EPI-07-0370.
42. PubMed Central. Alcohol and colorectal cancer risk: A comprehensive review. Cancer Epidemiol Biomarkers Prev [Internet]. 2023 [cited 2025 Jan 24]; Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6957715/
43. Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16:1599–1600. doi: 10.1016/S1470-2045(15)00444-1.
44. ScienceDirect. Article on colorectal cancer and associated risk factors. Available from: https://www.sciencedirect.com/science/article/pii/S1550728922007195.
45. ScienceDirect. Study on health implications and carcinogenic risks. Available from: https://www.sciencedirect.com/science/article/pii/S0022316623025282.
46. National Center for Biotechnology Information. Study on colorectal cancer mechanisms. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2915616/.
47. National Center for Biotechnology Information. The mechanisms of alcohol-induced colorectal cancer (CRC) highlight a higher risk for CRC development. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8431530/.
48. ScienceDirect. Excessive alcohol intake as a significant risk factor for colorectal cancer, with emphasis on moderate to high alcohol consumption. Available from: https://www.sciencedirect.com/science/article/pii/S0022316623030730.

49. National Center for Biotechnology Information. Study on alcohol and colorectal cancer mechanisms. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7477374/